tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

IPSC Stock Latest News

Century Therapeutics price target lowered to $9 from $11 at H.C. Wainwright
The FlyCentury Therapeutics price target lowered to $9 from $11 at H.C. Wainwright
10d ago
IPSC
Century Therapeutics initiated with a Buy at Rodman & Renshaw
PremiumThe Fly
Century Therapeutics initiated with a Buy at Rodman & Renshaw
17d ago
IPSC
Century Therapeutics initiated with a Buy at Rodman & Renshaw
PremiumThe Fly
Century Therapeutics initiated with a Buy at Rodman & Renshaw
17d ago
IPSC
Century Therapeutics Provides Investor Meeting Slide Update
PremiumCompany Announcements
Century Therapeutics Provides Investor Meeting Slide Update
17d ago
8K
IPSC
Century Therapeutics reports Q2 EPS (38c), consensus (46c)
PremiumThe Fly
Century Therapeutics reports Q2 EPS (38c), consensus (46c)
17d ago
IPSC
Century Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates
PremiumPress ReleasesCentury Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates
17d ago
IPSC
Century Therapeutics files to sell 7.87M shares of common stock for holders
Premium
The Fly
Century Therapeutics files to sell 7.87M shares of common stock for holders
2M ago
IPSC
Century Therapeutics price target raised to $12 from $9 at Piper Sandler
Premium
The Fly
Century Therapeutics price target raised to $12 from $9 at Piper Sandler
2M ago
IPSC
Century Therapeutics presents interim results from Phase 1 ELiPSE-1 study
PremiumThe Fly
Century Therapeutics presents interim results from Phase 1 ELiPSE-1 study
3M ago
IPSC
Century Therapeutics Presents Interim Results from Phase 1 ELiPSE-1 Study at ASCO 2024 Annual Meeting
PremiumPress Releases
Century Therapeutics Presents Interim Results from Phase 1 ELiPSE-1 Study at ASCO 2024 Annual Meeting
3M ago
IPSC
Century Therapeutics files to sell 15.87M shares of common stock for holders
PremiumThe Fly
Century Therapeutics files to sell 15.87M shares of common stock for holders
3M ago
IPSC
Century announces two presentations on CNTY-101 at ASGCT 27th Annual Meeting
PremiumThe Fly
Century announces two presentations on CNTY-101 at ASGCT 27th Annual Meeting
4M ago
IPSC
Century Therapeutics price target lowered to $11 from $13 at H.C. Wainwright
PremiumThe FlyCentury Therapeutics price target lowered to $11 from $13 at H.C. Wainwright
4M ago
IPSC
Century Therapeutics expects cash to support operations into 2026
Premium
The Fly
Century Therapeutics expects cash to support operations into 2026
4M ago
IPSC
Century Therapeutics reports Q1 EPS (45c) vs. (53c) last year
Premium
The Fly
Century Therapeutics reports Q1 EPS (45c) vs. (53c) last year
4M ago
IPSC
Century Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
PremiumPress Releases
Century Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
4M ago
IPSC
Century Therapeutics to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
PremiumPress Releases
Century Therapeutics to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
4M ago
IPSC
Century Therapeutics price target lowered to $9 from $10 at Piper Sandler
PremiumThe Fly
Century Therapeutics price target lowered to $9 from $10 at Piper Sandler
4M ago
IPSC
Century Therapeutics Executes Strategic Acquisition and Equity Sales
PremiumCompany Announcements
Century Therapeutics Executes Strategic Acquisition and Equity Sales
5M ago
8K
IPSC
Century Therapeutics Strengthens Position in Autoimmune Disease with Strategic Pipeline Expansion Supported by $60 Million Private Placement and Acquisition of Clade Therapeutics
PremiumPress ReleasesCentury Therapeutics Strengthens Position in Autoimmune Disease with Strategic Pipeline Expansion Supported by $60 Million Private Placement and Acquisition of Clade Therapeutics
5M ago
IPSC
Century Therapeutics announces strategic pipeline expansion
Premium
The Fly
Century Therapeutics announces strategic pipeline expansion
5M ago
IPSC
Century Therapeutics: Data from iPSC-derived cell therapy presented at AACR
Premium
The Fly
Century Therapeutics: Data from iPSC-derived cell therapy presented at AACR
5M ago
IPSC

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >